Condition: Severe Pulmonary Valve Regurgitation · Sponsor: Medtronic Cardiovascular
The Harmony Transcatheter Pulmonary Valve (TPV) System is indicated for use in the management of pediatric and adult congenital heart disease patients with severe pulmonary regurgitation (i.e., severe pulmonary regurgitation as determined by echocardiography and/or pulmonary regurgitant fraction ≥ 30% as determined by cardiac magnetic resonance imaging) who have a native or surgically-repaired right ventricular outflow tract and are clinically indicated for pulmonary valve replacement as judged by the medical team.
This description comes directly from the study's public registry record.
Petra Novakova · +31612591883 · rs.harmonyemeapms@medtronic.com
Always discuss trial participation with your own doctor first.
| Rigshospitalet | Copenhagen, Denmark | Recruiting |
| CHU de Bordeaux - Hôpital Cardiologique du Haut-Leveque | Bordeaux, France | Recruiting |
| Herz - und Diabeteszentrum NRW | Bad Oeynhausen, Germany | Recruiting |
| Charité - Universitätsmedizin Berlin | Berlin, Germany | Recruiting |
| Helios Health Institute Standort Leipzig | Leipzig, Germany | Recruiting |
| TUM University Hospital | Munich, Germany | Recruiting |
| Mater Misericordiae University Hospital | Dublin, Ireland | Recruiting |
| Schneider Children's Medical Center Israel | Petah Tikva, Israel | Recruiting |
| Policlinico di Sant'Orsola | Bologna, Italy | Recruiting |
| Azienda Ospedaliera di Padova | Padova, Italy | Not Yet Recruiting |
| Hospital General Universitario Gregorio Marañón | Madrid, Spain | Recruiting |
| Skånes Universitetssjukhus Lund | Lund, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06906926